Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a government funding notice banner and updated the page version to v3.4.1 (removing v3.4.0). The changes appear cosmetic and do not modify the study details, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2026-02-04T05:32:03.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Non-substantive UI and wording updates include adding a glossary toggle and minor capitalization changes to QC-related metadata and the revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:57:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 is now displayed on the page. This is a minor metadata update and does not modify the study details, eligibility criteria, or user actions.
    Difference
    0.1%
    Check dated 2026-01-14T02:39:41.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing California, Kentucky, Michigan, New Jersey, Pennsylvania, Tennessee, and Washington, plus a new revision note (v3.3.3). Removed the individual state location subsections (California Locations, Kentucky Locations, etc.) and the previous revision note (v3.3.2).
    Difference
    0.9%
    Check dated 2025-12-23T21:56:31.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no changes to study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:25:38.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    - Removed the government funding/operational status banner; the study details, eligibility criteria, and locations remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:50:42.000Z thumbnail image

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.